Abstract
Hypergammaglobulinemia is often found in patients with autoimmune diseases, such as systemic lupus erythematosus (SLE), and its level may correlate with disease activity. However, it is unclear whether immunoglobulin G (IgG) displays seasonal changes. We analyzed the seasonal change in serum IgG by assessing 450 patients with connective tissue disease. The serum IgG levels in summer were compared with those in winter from 2006 to 2009. Independent samples from 355 patients were analyzed to confirm results in the first set. The differences in the IgG levels between the two seasons were analyzed in each disease and compared with disease activity. 488 patients without connective tissue disease were analyzed as reference instead of healthy people as control. We found that connective tissue disease patients tended to show higher levels of serum IgG in summer than in winter every year from 2006 to 2009, whereas patients without connective tissue disease did not demonstrate such a tendency. We observed this seasonal tendency in each disease. Seasonal changes weakly correlated with those of anti-DNA antibody in SLE patients and those of disease activity score in rheumatoid arthritis (RA) patients. Serum IgG levels of patients with connective tissue diseases display seasonal variations. Biological and clinical significance of these variations should be elucidated.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Ehrenstein MR, Isenberg DA. Hypergammaglobulinaemia and autoimmune rheumatic diseases. Ann Rheum Dis. 1992;51(11):1185–7.
Hahn BH. Antibodies to DNA. N Engl J Med. 1998;338(19):1359–68.
Schur PH, Sandson J. Immunologic factors and clinical activity in systemic lupus erythematosus. N Engl J Med. 1968;278(10):533–8.
ter Borg EJ, Horst G, Hummel EJ, Limburg PC, Kallenberg CG. Measurement of increases in anti-double-stranded DNA antibody levels as a predictor of disease exacerbation in systemic lupus erythematosus. A long-term, prospective study. Arthritis Rheum. 1990;33(5):634–43.
Saito T, Fukuda H, Arisue M, Matsuda A, Shindoh M, Amemiya A, et al. Periductal lymphocytic infiltration of salivary glands in Sjogren’s syndrome with relation to clinical and immunologic findings. Oral Surg Oral Med Oral Pathol. 1991;71(2):179–83.
Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988;31(3):315–24.
Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997;40(9):1725.
Lonzetti LS, Joyal F, Raynauld JP, Roussin A, Goulet JR, Rich E, et al. Updating the American College of Rheumatology preliminary classification criteria for systemic sclerosis: addition of severe nailfold capillaroscopy abnormalities markedly increases the sensitivity for limited scleroderma. Arthritis Rheum. 2001;44(3):735–6.
Fujibayashi T, Sugai S, Miyasaka N, Hayashi Y, Tsubota K. Revised Japanese criteria for Sjogren’s syndrome (1999): availability and validity. Mod Rheumatol. 2004;14(6):425–34.
Doria A, Ghirardello A, de Zambiasi P, Ruffatti A, Gambari PF. Japanese diagnostic criteria for mixed connective tissue disease in Caucasian patients. J Rheumatol. 1992;19(2):259–64.
Bohan A, Peter JB. Polymyositis and dermatomyositis (first of two parts). N Engl J Med. 1975;292(7):344–7.
Komai K, Shiozawa K, Tanaka Y, Yoshihara R, Tanaka C, Sakai H, et al. Sjogren’s syndrome patients presenting with hypergammaglobulinemia are relatively unresponsive to cevimeline treatment. Mod Rheumatol. 2009;19(4):416–9.
Miyamae T, Ito S, Machida H, Ozawa R, Higuchi R, Nakajima S, et al. Clinical features and laboratory findings in children with both anti-dsDNA and anti-U1-RNP antibody. Nihon Rinsho Meneki Gakkai Kaishi. 2008;31(5):405–14.
Hasan T, Pertovaara M, Yli-Kerttula U, Luukkaala T, Korpela M. Seasonal variation of disease activity of systemic lupus erythematosus in Finland: a 1 year follow up study. Ann Rheum Dis. 2004;63(11):1498–500.
Amit M, Molad Y, Kiss S, Wysenbeek AJ. Seasonal variations in manifestations and activity of systemic lupus erythematosus. Br J Rheumatol. 1997;36(4):449–52.
Haga HJ, Brun JG, Rekvig OP, Wetterberg L. Seasonal variations in activity of systemic lupus erythematosus in a subarctic region. Lupus. 1999;8(4):269–73.
Sarkar K, Weinberg CR, Oddis CV, Medsger TA Jr, Plotz PH, Reveille JD, et al. Seasonal influence on the onset of idiopathic inflammatory myopathies in serologically defined groups. Arthritis Rheum. 2005;52(8):2433–8.
Phillips BA, Zilko PJ, Garlepp MJ, Mastaglia FL. Seasonal occurrence of relapses in inflammatory myopathies: a preliminary study. J Neurol. 2002;249(4):441–4.
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
About this article
Cite this article
Terao, C., Ohmura, K., Yamamoto, K. et al. Serum IgG levels demonstrate seasonal change in connective tissue diseases: a large-scale, 4-year analysis in Japanese. Mod Rheumatol 22, 426–430 (2012). https://doi.org/10.1007/s10165-011-0535-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10165-011-0535-3